骨折终生风险的遗传预测
该基于人群的前瞻性研究纳入3515名60岁及以上社区居住个体,随访长达20年,采用骨密度相关变异构建多基因风险评分,发现评分高于中位数者骨折终生风险高于人群平均水平,提示多基因风险评分可能用于个性化骨折风险评估。
要点
- 女性与男性死亡校正后骨折终生风险分别为36%和21%。
- 多基因风险评分高于中位数4.24者骨折风险高于人群平均,女性为1.2倍、男性为1.1倍。
- 高多基因风险评分者髋部骨折风险显著升高,女性1.5倍、男性1.3倍。
核心结论
- 基于骨密度相关遗传变异的多基因风险评分与骨折终生风险相关,提示可将多基因风险评分纳入个性化骨折风险评估。
研究设计与样本
- 基于人群的前瞻性研究,纳入3515名60岁及以上社区居住个体,随访长达20年。
主要发现
- 女性死亡校正后骨折终生风险为36%(95%CI 34%-39%),男性为21%(95%CI 18%-24%)。
- 多基因风险评分高于中位数4.24者骨折风险高于人群平均水平,女性为1.2倍、男性为1.1倍。
- 女性髋部骨折平均终生风险为10%(95%CI 8%-12%),男性约为5%(95%CI 3%-7%)。
- 高多基因风险评分者髋部骨折风险显著升高,女性为1.5倍、男性为1.3倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Fragility fracture is a significant public health problem because it is associated with increased mortality. We want to find out whether the risk of fracture can be predicted from the time of birth. OBJECTIVE: To examine the association between a polygenic risk score (PRS) and lifetime fracture risk. METHODS: This population-based prospective study involved 3515 community-dwelling individuals aged 60+ years who have been followed for up to 20 years. Femoral neck bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry. A PRS was created by summing the weighted number of risk alleles for each single nucleotide polymorphism using BMD-associated coefficients. Fragility fractures were radiologically ascertained, whereas mortality was ascertained through a state registry. Residual lifetime risk of fracture (RLRF) was estimated by survival analysis. RESULTS: The mortality-adjusted RLRF for women and men was 36% (95% CI, 34%-39%) and 21% (18%-24%), respectively. Individuals with PRS > 4.24 (median) had a greater risk (1.2-fold in women and 1.1-fold in men) than the population average risk. For hip fracture, the average RLRF was 10% (95% CI, 8%-12%) for women and ∼5% (3%-7%) for men; however, the risk was significantly increased by 1.5-fold and 1.3-fold for women and men with high PRS, respectively. CONCLUSION: A genetic profiling of BMD-associated genetic variants is associated with the residual lifetime risk of fracture, suggesting the potential for incorporating the polygenic risk score in personalized fracture risk assessment.
引用
- Ho-Le TP, Tran TS, Nguyen HG, et al. Genetic Prediction of Lifetime Risk of Fracture. J Clin Endocrinol Metab. 2023. PMID: 37165700. doi:10.1210/clinem/dgad254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。